Endocrine Testing Market To Record Impressive Growth, Revenue To Surge To US$10.50 Bn By 2021

06-Sep-2018 | Zion Market Research

With the presence of a large pool of participants, the global endocrine testing market is displaying a highly competitive business landscape, finds a new research report by Zion Market Research (ZMR). Quest Diagnostics, Bio Rad Laboratories, F. Hoffmann-La Roche AG, Abbott Laboratories, Agilent Technologies, and bioMerieux SA are some of the key vendors of endocrine testing across the world. These players across endocrine testing market are focusing aggressively on innovation, as well as on including advanced technologies in their existing products. Over the coming years, they are also expected to take up partnerships and mergers and acquisitions as their key strategy for business development, states the endocrine testing market study.

Citing an instance, in May 2018, Interpace Diagnostics Group Incorporation, a fully integrated commercial & bioinformatics firm providing molecular diagnostics tests, declared that will launch a new thyroid test referred as ThyGeNEXT®, the next-generation of ThyGenX®, at American Association of Clinical Endocrinologists Annual Meeting in Boston.

Request Sample Request Customization Buy Now

This review is based on a report by Zion Market Research, titled "Endocrine Testing Market (Dehydroepiandrosterone Sulfate, Progesterone, Luteinizing Hormone, Estradiol, Human Chorionic Gonadotropin, Follicle Stimulating, Testosterone, Thyroid Prolactin, Thyroid Stimulating Hormone, Cortisol, Insulin, and Other Tests) By Technology (Monoclonal & Polyclonal Antibody Technologies, Tandem Mass Spectrometry, Immunoassay, Clinical Chemistry Technologies, and Others) for End-use Commercial Laboratories, Home-Based Tests, Ambulatory Care Centers, Hospitals and Other End-users: Global Industry Perspective, Comprehensive Analysis and Forecast, 2015 - 2021"- Report at http://www.zionmarketresearch.com/report/endocrine-testing-market

As estimated in this report, the global endocrine testing market stood at US$ 7 billion in 2015. Witnessing a tremendous rise during the period from 2015 to 2021, the revenue in this endocrine testing market is expected to reach US$ 10.50 billion by the end of the forecast period. The main test types available in this endocrine testing market are dehydroepiandrosterone sulfate, estradiol, luteinizing hormone, thyroid stimulating hormone, and human chorionic gonadotropin. Among them, the demand for thyroid stimulating hormone is relatively higher and the trend is anticipated to remain so over the next few years, notes the research report.

Global Endocrine nTesting Market

Ascending Healthcare Awareness & Government Support To Spur Market Growth

“Mounting health awareness, early endocrine disorder diagnosis, and favorable government policies is predicted to inflate the growth of endocrine testing market over the ensuing years,” says the author of this study. Apart from this, exponential increase in diabetes patients and elderly & obese population is forecast to augment the endocrine testing market size over the forthcoming years.

Soaring technology costs, however, is projected to inhibit the progression of endocrine testing market over the next few years. Nevertheless, massive funding of R&D activities and technological innovations are expected to open new growth opportunities for the business, thereby normalizing the impact of hindrances on the endocrine testing market, reports the endocrine testing market study.

Huge Presence Of Healthcare Hospitals To Support North America’s Dominance

Regionally, North America has been leading the worldwide endocrine testing market and is anticipated to continue on the dominant position in the years to come, states the endocrine testing market study. The well-established presence of primary, secondary, and tertiary healthcare care hospitals is the main factor behind the dominance of the North America endocrine testing market. In addition, favorable compensation policies, massive government investments, and awareness about health among the population of North America will further supplement the growth of the regional market in the next few years span. Application of innovative methods for endocrine testing purpose in North America will further dilate the market demand.

The global endocrine testing market is segmented as follows:

By Test

  • Dehydroepiandrosterone sulfate (DHEAS)
  • Progesterone
  • Luteinizing Hormone (LH)
  • Estradiol (E2)

By Region

  • North America
    • The U.S.
  • Europe
    • UK
    • France
    • Germany
  • Asia Pacific
    • China
    • Japan
    • India
  • Latin America
    • Brazil
  • The Middle East and Africa

About Us:
Zion Market Research is an obligated company. We create futuristic, cutting-edge, informative reports ranging from industry reports, the company reports to country reports. We provide our clients not only with market statistics unveiled by avowed private publishers and public organizations but also with vogue and newest industry reports along with pre-eminent and niche company profiles. Our database of market research reports comprises a wide variety of reports from cardinal industries. Our database is been updated constantly in order to fulfill our clients with prompt and direct online access to our database. Keeping in mind the client’s needs, we have included expert insights on global industries, products, and market trends in this database. Last but not the least, we make it our duty to ensure the success of clients connected to us—after all—if you do well, a little of the light shines on us.

Contact Us:
Zion Market Research
244 Fifth Avenue, Suite N202
New York, 10001, United States
Tel: +49-322 210 92714
USA/Canada Toll-Free No.1-855-465-4651
Email: sales@zionmarketresearch.com
Website: https://www.zionmarketresearch.com

Download Brochure
Latest Published Reports

View All Published Reports